A Phase 2 Trial of Anakinra for the Prevention of CAR-T Cell Mediated Neurotoxicity

Clinical trial NCT04150913 · COMPLETED

Trial details

NCT number: NCT04150913
Sponsor: Marcela V. Maus, M.D.,Ph.D.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Non Hodgkin Lymphoma Refractory Non-Hodgkin Lymphoma Relapsed Non Hodgkin Lymphoma Neurotoxicity Neurotoxicity Syndromes Cytokine Release Syndrome

Start date: 2020-10-01
Primary completion: 2023-10-30
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.